Pasar al contenido principal

MICRORNAS EN LA INFECCION POR TRYPANOSOMA CRUZI: INMUNOPATOGENIA Y APLICACIONES TRASLACIONALES.

SAF2015-63868-R

•
Nombre agencia financiadora Ministerio de Economía y Competitividad
Acrónimo agencia financiadora MINECO
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2015
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Unidad de gestión Dirección General de Investigación Científica y Técnica
Centro beneficiario UNIVERSIDAD AUTONOMA DE MADRID
Identificador persistente http://dx.doi.org/10.13039/501100003329

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Differential cytokine profiling in Chagasic patients according to their arrhythmogenic-status

  • Rodríguez-Angulo, Héctor
  • Marqués, Juan
  • Mendoza, Iván
  • Villegas, Marco
  • Mijares, Alfredo
  • Gironès, Núria
  • Fresno, Manuel
[Background] Changas disease is caused by the protozoan Trypanosoma cruzi and is characterized by heart failure and sudden death. Identifying which factors are involved in evolution and treatment response is actually challenging. Thus, the aim of this work was to determine the Th1/Th17 (IL-6, IL-2, TNF, IL-17 and IFN-γ) and Th2 (IL-4 and IL-10) serum profile in Venezuelan Chagasic patients stratified according amiodarone treatment, hypertension and arrhythmias., [Methods] Sera from 38 chagasic patients were analyzed to determine the level of cytokines by Multiplexed Bead-Based Immunoassays. ANOVA test was applied to determine differences for each group. Additionally, a Linear Discriminant Analysis (LDA) was applied to observe the accuracy of different cytokines to discriminate between the groups., [Results] The levels of several cytokines were significantly higher in the high-risk of sudden death and untreated group. LDA showed that IL-2, IFN-γ and IL-10 were the best cytokines for discriminating between high-risk of sudden death and untreated patients versus low-risk of sudden death, treated and control groups., [Conclusions] High IL-2 levels seem to identify patients with high-risk of sudden death and seems adequate as treatment efficacy marker. To our knowledge, this is the first report about the anti-inflammatory role of the amiodarone in Chagas disease, suggesting an inmunomodulatory effect that may be exploited as coadjutant therapy in chronic Chagas disease., This work was supported by MF grant (SN/2013) and NG grant (CEAL-AL/2015-12) from “UAM-Banco Santander” for collaboration with Latin America; by NG grants from “Fondo de Investigaciones Sanitarias/FEDER” (PS09/00538 and PI12/00289), MINECO/FEDER (SAF2015-63868-R) “Universidad Autónoma de Madrid” and “Comunidad de Madrid” (CC08-UAM/SAL-4440/08); by MF grants from “Ministerio de Ciencia e Innovación” (SAF2010-17833 and SAF2013-42850-R), MINECO/FEDER (SAF2016-75998-R), “Red de Investigación de Centros de Enfermedades Tropicales” (RICET RD12/0018/0004; RICET RD16/0027/0006); European Union (HEALTH-FE-2008-22303, ChagasEpiNet, HOMIN - 317057 - FP7-PEOPLE-2012-ITN); AECID (A/025417/09 and A/031735/10), Comunidad de Madrid (S-2010/BMD-2332), Proyecto Excelencia BIOIMID - IIS La Princesa and “Fundación Ramón Areces”; and by HR and AM grants from Instituto Venezolano de Investigaciones Científicas (IVIC-1365)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Genome sequence of Trypanosoma cruzi strain Bug2148

  • Callejas-Hernández, Francisco
  • Gironès, Núria
  • Fresno, Manuel
Trypanosoma cruzi belongs to the group of mitochondrion-containing eukaryotes and has a highly plastic genome, unusual gene organization, and complex mechanisms for gene expression (polycistronic transcription). We report here the genome sequence of strain Bug2148, the first genomic sequence belonging to cluster TcV, which has been related to vertical transmission., Consejo de Ciência, Tecnología e Innovación de Hidalgo (CITNOVA, Mexico); by Ministerio de Economía y Competitividad grant SAF2015-63868-R (MINECO/FEDER) to N.G. and SAF2016-75988-R (MINECO/FEDER) to M.F.; by Red de Investigación Colaborativa en Enfermedades Tropicales (RICET grant RD12/0018/0004) to M.F.; by the European Union (grant HEALTH-FE-2008-22303, ChagasEpiNet) to M.F.; and by the Comunidad de Madrid (grant S-2010/BMD-2332) and institutional grants from Fundación Ramón Areces., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Quantitative proteomic analysis of macrophages infected with Trypanosoma cruzi reveals different responses dependent on the SLAMF1 receptor and the parasite strain

  • Herreros-Cabello, Alfonso
  • Moral-Salmoral, Javier del
  • Morato-López, Esperanza
  • Marina-Ramírez, Anabel
  • Barrocal, Beatriz
  • Fresno, Manuel
  • Gironès, Núria
This article belongs to the Section Molecular Microbiology., Chagas disease is caused by the intracellular protozoan parasite <i>Trypanosoma cruzi</i>. This disease affects mainly rural areas in Central and South America, where the insect vector is endemic. However, this disease has become a world health problem since migration has spread it to other continents. It is a complex disease with many reservoirs and vectors and high genetic variability. One of the host proteins involved in the pathogenesis is SLAMF1. This immune receptor acts during the infection of macrophages controlling parasite replication and thus affecting survival in mice but in a parasite strain-dependent manner. Therefore, we studied the role of SLAMF1 by quantitative proteomics in a macrophage in vitro infection and the different responses between Y and VFRA strains of <i>Trypanosoma cruzi</i>. We detected different significant up- or downregulated proteins involved in immune regulation processes, which are SLAMF1 and/or strain-dependent. Furthermore, independently of SLAMF1, this parasite induces different responses in macrophages to counteract the infection and kill the parasite, such as type I and II IFN responses, NLRP3 inflammasome activation, IL-18 production, TLR7 and TLR9 activation specifically with the Y strain, and IL-11 signaling specifically with the VFRA strain. These results have opened new research fields to elucidate the concrete role of SLAMF1 and discover new potential therapeutic approaches for Chagas disease., This research was supported by the Ministerio de Economía y competitividad and Fondo Europeo de Desarrollo Regional (SAF2016-75988-R (MINECO/FEDER), SAF2015-63868-R (MINECO/FEDER) to M.F.), Ministerio de Ciencia, Innovación y Universidades-Agencia Estatal de Investigación and Fondo Europeo de Desarrollo Regional (PGC2018-096132-B-I00 and PID2021-123389OB-I00 to N.G.). A.H-C. was a recipient of a FPU contract from the Ministerio de Ciencia, Innovación y Universidades; J.M-S. was a recipient of a Garantía Juvenil predoctoral fellowship (Comunidad de Madrid). Grant PT17/0019, of the PE I + D + i 2013-2016, funded by ISCIII and ERDF., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Discovery of circulating miRNAs as biomarkers of chronic Chagas heart disease via a small RNA-Seq approach

  • Villar, Silvina R
  • Herreros-Cabello, Alfonso
  • Callejas-Hernández, Francisco
  • Maza, María C
  • Del Moral-Salmoral, Javier
  • Gómez-Montes, Mario
  • Rodríguez-Angulo, Héctor O
  • Carrillo, Irene
  • Górgolas, Miguel
  • Bosch-Nicolau, Pau
  • Molina, Israel
  • Pérez-Molina, José A
  • Monge-Maillo, Begoña
  • Bottasso, Oscar A
  • Beloscar, Juan
  • Pérez, Ana R
  • Fresno, Manuel
  • Gironès, Núria
Chagas disease affects approximately 7 million people worldwide in Latin America and is a neglected tropical disease. Twenty to thirty percent of chronically infected patients develop chronic Chagas cardiomyopathy decades after acute infection. Identifying biomarkers of Chagas disease progression is necessary to develop better therapeutic and preventive strategies. Circulating microRNAs are increasingly reliable biomarkers of disease and therapeutic targets. To identify new circulating microRNAs for Chagas disease, we performed exploratory small RNA sequencing from the plasma of patients and performed de novo miRNA prediction, identifying potential new microRNAs. The levels of the new microRNAs temporarily named miR-Contig-1519 and miR-Contig-3244 and microRNAs that are biomarkers for nonchagasic cardiomyopathies, such as miR-148a-3p and miR-224-5p, were validated by quantitative reverse transcription. We found a specific circulating microRNA signature defined by low miR-Contig-3244, miR-Contig-1519, and miR-148a-3 levels but high miR-224-5p levels for patients with chronic Chagas disease. Finally, we predicted in silico that these altered circulating microRNAs could affect the expression of target genes involved in different cellular pathways and biological processes, which we will explore in the future., The funding was supported by Agencia Nacional e Promoción Científica y Tecnológica, PICT 2013-1892, Secretaría de Ciencia y Tecnología, Universidad Nacional de Rosario, 1MED410, Ministerio de Economía y competitividad and Fondo Europeo de Desarrollo Regional, SAF2016-75988-R (MINECO/FEDER), SAF2015-63868-R (MINECO/FEDER), Red de Investigación de Centros de Enfermedades Tropicales, RICET RD12/0018/0004, Consejería de Sanidad, Comunidad de Madrid, S-2010/BMD-2332, Ministerio de Ciencia, Innovación y Universidades-Agencia Estatal de Investigación and Fondo Europeo de Desarrollo Regional, PGC2018-096132-B-I00, and PID2021-123389OB-I00.